Company Name: Immunomedics, Inc.
Immunomedics, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of monoclonal antibody-based therapeutics for cancer, autoimmune disorders and other serious diseases.
Ticker Symbol: IMMU (NASDAQ)
Company Website: www.immunomedics.com
Social Media: Immunomedics LinkedIn
Headquarters: Morris Plains, NJ